β-Peptido sulfonamides: For-Met-Leu-Phe-OMe analogues containing taurine and chiral β-amino-ethanesulfonic acid residues

Farmaco

Volumn 59, Issue 12, 2004, Pages 953-963

  Giordano, Cesare ^a   Nalli, Marianna ^a   Paradisi, Mario Paglialunga ^a   Sansone, Anna ^a   Lucente, Gino ^a   Spisani, Susanna ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Peptido sulfonamides; Chemotactic peptides; Human neutrophils; Pseudopeptides; Taurine

Indexed keywords

BETA AMINOCARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; SULFONAMIDE; SULFONIC ACID DERIVATIVE; TAURINE; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; CONFORMATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION;

CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOLAMINES; HUMANS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; STEREOISOMERISM; SULFONAMIDES; SULFONIC ACIDS; TAURINE;

EID: 10344232467     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2004.07.014     Document Type: Article

References (21)

1. Giordano C., Lucente G., Nalli M., Pagani Zecchini G., Paglialunga Paradisi M., Varani K., and Spisani S. Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing β-alanine or taurine at the central position Farmaco 58 2003 1121 1130
2. 3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide for-Met-Leu-Phe-OMe J. Peptide Sci. 10 2004 510 523
3. 3-peptides with proteinaceous side chains. Synthesis and solution structures of constitutional isomers, a novel helical secondary structure, and the influence of salvation and hydrophobic interactions on folding Helv. Chim. Acta 81 1998 932 982
4. 3-amino acid insertion in a peptide Eur. J. Biochem. 270 2003 939 949
5. Freer R.J., Day A.R., Radding J.A., Schiffmann E., Aswanikumar S., Showell H.J., and Becker E.L. Further studies on the structural requirements for synthetic peptide chemoattractants Biochemistry 19 1980 2404 2410
6. Derian C.K., Solomon H.F., Higgins J.D. III, Beblavy M.J., Santulli R.J., Bridger G.J., Pike M.C., Kroon D.J., and Fischman A.J. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues Biochemistry 35 1996 1265 1269
7. Calcagni A., Gavuzzo E., Lucente G., Mazza F., and Pochetti G. Structure and conformation of peptides containing the sulphonamide junction Int. J. Peptide Protein Res. 34 1989 319 324
8. Calcagni A., Gavuzzo E., Lucente G., Mazza F., Pinnen F., Pochetti G., and Rossi D. Structure and conformation of peptides containing the sulphonamide junction. II. Synthesis and conformation of cyclo[-MeTau-Phe-DPro-] Int. J. Peptide Protein Res. 34 1989 471 479
9. Calcagni A., Gavuzzo E., Lucente G., Mazza F., Pinnen F., Pochetti G., and Rossi D. Synthesis, crystal and molecular structure of a taurine containing peptidic oxa-cyclol Int. J. Peptide Protein Res. 37 1991 167 173
10. 2 Tetrahedron Lett. 32 1991 6779 6782
11. Calcagni A., Rossi D., Paglialunga Paradisi M., Lucente G., Luisi G., Gavuzzo E., Mazza F., Pochetti G., and Paci M. Peptides containing the sulfonamide junction: synthesis, structure, and conformation of Z-Tau-Pro-Phe-NHiPr Biopolymers 41 1997 555 567
12. Calcagni A., Gavuzzo E., Lucente G., Mazza F., Morera E., Paglialunga Paradisi M., and Rossi D. Peptides containing the sulfonamide junction: 2. Structure and conformation of Z-Tau-Pro-D-Phe-NHiPr Biopolymers 54 2000 379 387
13. Calcagni A., Gavuzzo E., Mazza F., Pinnen F., Pochetti G., and Rossi D. Structure and conformation of peptides containing the sulphonamide junction. IV. Synthesis and crystal conformation of N-benzoyl-l-phenylalanyl-tauryl-l-leucine methyl ester Gazz. Chim. Ital. 122 1992 17 23
14. Freer R.J., Day A.R., Muthukumaraswamy N., Pinon D., Wu A., Showell H.J., and Becker E.L. Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils Biochemistry 21 1982 257 263
15. Torrini I., Paglialunga Paradisi M., Pagani Zecchini G., Lucente G., Mastropietro G., and Spisani S. Bioactive fMLF-OMe analogs containing a N-terminal oximic or formylhydrazonic moiety J. Pept. Res. 55 2000 102 109 (references therein)
16. Torrini I., Pagani Zecchini G., Paglialunga Paradisi M., and Spisani S. The role of (Z)-2,3-didehydrophenylalanine C-terminal residue in determining the chemotactic activity of formylpeptides Arch. Phar. Pharm. Med. Chem. 329 1996 143 148
17. Brouwer A.J., Monnee M.C.F., and Liskamp R.M.J. An efficient synthesis of N-protected β-aminoethanesulfonyl chlorides: versatile building blocks for the synthesis of oligopeptidosulfonamides Synthesis 11 2000 1579 1584
18. Diaz J., Cazaubon C., Demarna H., Gagno J.P., Guegan R., Muneaux Y., Perreaut P., Richaud J.P., Vedel M., and Roncucci R. Eur. J. Med. Chem. Chim. Ther. 20 1985 219 227
19. Lajoie G., and Kraus J.L. Rapid and efficient method for the N-formylation of C-blocked peptides Peptides 5 1984 653 654
20. Edmundson A.B., and Ely K.R. Binding of N-formylated chemotactic peptides in crystals of the Mcg light chain dimer: similarities with neutrophil receptors Molecular Immunology 22 1985 463 475
21. Zigmond S.H., and Hirsch J.G. Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of cell-derived chemotactic factor J. Exp. Med. 137 1973 387 410